Advertisement

How do Changes in the GH/IGF-1 Status of the Elderly Occurring Naturally, Pathologically or Therapeutically-Induced Impact on their Lives

  • S. K. Abdul Shakoor
  • Andrew A. Toogood
  • Stephen M. Shalet
Part of the Research and Perspectives in Endocrine Interactions book series (RPEI)

Abstract

There is a progressive failure of numerous organ systems with increasing age in humans. The reduction in lean body mass, increased adiposity, and reduced bone mineral density associated with aging, contribute to the increasing lack of physical strength, poor mobility, fractures, and increased cardiovascular risk profile. Similar changes are also observed in adults with growth hormone deficiency (GHD), some of which have been shown to improve with growth hormone replacement. This has led to the theory that the relative reduction in GH and IGF-1 levels with increasing age (somatopause) may be causal with regard to these changes. In this review, we will consider changes in the GH/IGF-1 axis with increasing age and their implications, the effect of GH use in healthy elderly subjects, the impact of GHD in the elderly with hypothalamic pituitary disease and the response to GH replacement.

Keywords

Growth Hormone Elderly Subject Lean Body Mass Growth Hormone Deficiency Recombinant Human Growth Hormone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arvat E, Gianotti L, Grottoli S et al (1994) Arginine and growth hormone -releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects. J Clin Endocrinol Metab 79: 1440–1443.PubMedCrossRefGoogle Scholar
  2. Blackman MR, Sorkin JD, Munzer T, Bellantoni MF, Busby-Whitehead J, Stevens TE, Jayme J, O’Connor KG, Christmas C, Tobin JD, Stewart KJ, Cottrell E, St Clair C, Pabst KM, Harman SM(2002) Growth hormone and sex steroid administration in healthy aged women and men. JAMA 288: 2282–2292Google Scholar
  3. Cappola AR, Bandeen-Roche K, Wand GS, Volpato S, Fried LP(2001) Association of IGF-1 levels with muscle strength and mobility in older women. J Clin Endocrinol Metab 86(9): 4139–4146Google Scholar
  4. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M(1998) Plasma insulin like growth factor-land prostate cancer risk: a prospective study. Science 279: 563–566Google Scholar
  5. Chapman IM, Bach MA, Van Cauter E, Farmer M, Krupa D, Taylor AM, Schilling LM, Cole KY, Skiles EH, Pezzoli SS, Hartman ML, Veldhuis JD, Gormley GJ, Thorner MO (1996) Stimulation of the GH-IGF-1 axis by daily oral administration of a GH secretagogue (MK-677) in healthy elderly subjects. J Clin Endocrinol Metab 81: 4249–4257PubMedCrossRefGoogle Scholar
  6. Christmas C, O’Connor KG, Harman SM, Tobin JD, Munzer T, Bellantoni MF, Clair CS, Pabst KM, Sorkin JD, Blackman MR (2002) Growth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men. J Gerontol A Biol Sci 57 (1): M12–8CrossRefGoogle Scholar
  7. Chu LW, Lam KS, Tam SC, Hu WJ, Hui SL, Chiu A, Chiu KC, Ng P (2001) A randomised controlled trial of low dose recombinant growth hormone in the treatment of malnourished elderly medical patients. J Clin Endocrinol metab 86: 1913–1920PubMedCrossRefGoogle Scholar
  8. Cohn L, Feller AG, Draper MW, Rudman IW, Rudman D (1993) Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-1 concentrations. Clin Endocrinol 39: 417–425CrossRefGoogle Scholar
  9. Colao A, Cerbone G, Pivonello R, Klain M, Aimaretti G, Faggiano A, Di Somma C, Salvatore M, Lombardi G (1998) Growth hormone deficiency in elderly patients with hypothalamic pituitary tumours. Pituitary 1 (1): 59–67PubMedCrossRefGoogle Scholar
  10. Corpas E, Harman SM, Pineyro MA, Roberson R, Blackman MR (1992) Growth hormone -releasing hormone (1–29) twice daily reverses the decreased GH and insulin like growth factor-1 levels in old men J Clin Endocrinol Metab 75: 530–535.Google Scholar
  11. Corpas E, Harman SM, and Blackman MR (1993) Human growth hormone and human aging Endocrine Rev 14 (1): 20–39Google Scholar
  12. Corpas E, Harman SM, Pineyro MA, Roberson R, Blackman MR (1993) Continuous subcutaneous infusions of growth hormone releasing hormone 1–44 for 14 days increase GH and IGF-1 levels in old men. J Clin Endocrinol Metab 76: 134–138PubMedCrossRefGoogle Scholar
  13. Elahi D, Muller DC, Tzankoff SP, Andres R, Tobin JD (1982) Effect of age and obesity on fasting levels of glucose, insulin, glucagon, and growth hormone in men. J Gerontol 37: 385–391PubMedCrossRefGoogle Scholar
  14. Fernholm R, Bramnert M, Hagg E, Hilding A, Baylink DJ, Mohan S, Thoren M (2000) Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease. J Clin Endocrinol Metab 85 (11): 4104–12PubMedCrossRefGoogle Scholar
  15. Finkelstein JW, Roffwarg HP, Boyar RM, Kream J, Hellman L (1972) Age related change in the twenty-four hour spontaneous secretion of growth hormone. J Clin Endocrinol Metab 35: 665–670PubMedCrossRefGoogle Scholar
  16. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD (1996) Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Mineral Res 11: 337–349CrossRefGoogle Scholar
  17. Ghigo E, Arvat E, Gianotti L, Lanfranco F, Broglio F, Aimaretti G, Maccario M, Camanni F(2000) Hypothalamic growth hormone-Insulin like growth factor-I axis across the human life Span. J Paed Endocrinol Metab: 13, 1493–1502Google Scholar
  18. Ghiron LJ, Thompson JL, Holloway L, Hintz RL, Butterfield GE, Hoffman AR, Marcus R (1995) Effects of recombinant insulin like growth factor-1 and growth hormone on bone turnover in elderly women. J Bone Miner Res 10 (12): 1844–52PubMedCrossRefGoogle Scholar
  19. Hartman ML, Pezzoli SS, Hellmann PJ, Suratt PM, Thorner MO (1996) Pulsatile growth hormone secretion in older persons is enhanced by fasting without relationship to sleep stages. J Clin Endocrinol Metab 81: 2694–2701PubMedCrossRefGoogle Scholar
  20. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO (1987) Effects of sex and age on the 24 hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 64: 51–58PubMedCrossRefGoogle Scholar
  21. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM (1994) Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 78: 669–74.PubMedCrossRefGoogle Scholar
  22. Iranmanesh A, Lizarralde GB, Veldhuis JD (1991) Age and relative obesity are specific negative determinants of the frequency and amplitude of growth hormone secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 73: 1081–1088.PubMedCrossRefGoogle Scholar
  23. Iranmanesh A, Grisso B, Veldhuis JD (1994) Low basal and persistent pulsatile growth hormone secretion are revealed in normal and hyposomatotropic men studied with a new ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab 78: 526–535.PubMedCrossRefGoogle Scholar
  24. Janssen JAMJL, Stolk RP, Pols HAP et al (1998) Serum free IGF-I, total IGF-I, IGFBP-I and IGFBP3 levels in an elderly population: relation to age and sex steroid levels. Clin Endocrinol 48: 471–478CrossRefGoogle Scholar
  25. Janssen JA, Burger H, Stolk RP, Grobbee DE, de Jong FH, Lamberts SW, Pols HA (1998) Gender-specific relationship between serum free and total IGF-I and bone mineral density in elderly men and women. Eur J Endocrinol 138: 627–632PubMedCrossRefGoogle Scholar
  26. Janssen JA, Stolk RP, Pols HA, Grobbee DE, Lamberts SW (1998) Serum free and total insulin like growth factor-1, insulin like growth factor binding protein-1 and insulin like growth factor binding protein-3 levels in healthy elderly individuals. Gerontology. 44: 277–280.PubMedCrossRefGoogle Scholar
  27. Janssen YJH, Hamdy NAT, Frolich M and Roelfsema F (1998) Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone in patients with adult onset GH deficiency. J Clin Endocrinol Metab 83, (6); 2143–48PubMedCrossRefGoogle Scholar
  28. Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebaek NE (1994) The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endocrinol 41: 85–93.Google Scholar
  29. Kaiser FE, Silver AJ, and Morley JE (1991) The effect of recombinant human growth hormone on malnourished older individuals. J Am Geriatr Soc 39: 235–240PubMedGoogle Scholar
  30. Kalk WJ, Vinik AI, Pimstone BL, Jackson PU (1973) Growth hormone response to insulin hypoglycaemia in the elderly. J Gerontol 28: 431–433PubMedCrossRefGoogle Scholar
  31. Kalmijn S, Janssen JA, Pols HA, Lamberts SW, Breteler MM (2000) A prospective study on circulating insulin like growth factor-1, IGF-binding proteins, and cognitive function in the elderly. J Clin Endocrinol Metab 85: 4551–4555.Google Scholar
  32. Khorram O, Laughlin GA, Yen SS (1997) Endocrine and metabolic effects of long term administration of (Nle27) growth hormone releasing hormone (1–29)-NH2 in age advanced men and women. J Clin Endocrinol Metab 82 (5): 1472–9PubMedCrossRefGoogle Scholar
  33. Kiel DP, Puhl J, Rosen CJ, Berg K, Murphy JB, MacLean DB (1998) Lack of an association between insulin like growth factor-1 and body composition, muscle strength, physical performance or self reported mobility among older persons with functional limitations. J Am Geriatr Soc 46 (7): 822–828PubMedGoogle Scholar
  34. Lange KH, Andersen JL, Beyer N, Isaksson F, Larsson B, Rasmussen MH, Juul A, Bulow J, Kjaer M (2002) GH administration changes myosin heavy chain isoforms in skeletal muscle but does not augment muscle strength or hypertrophy, either alone or combined with resistance exercise training in healthy elderly men. J Clin Endocrinol Metab 87: 513–523PubMedCrossRefGoogle Scholar
  35. Langlois JA, Rosen CJ, Visser M, Hannan MT, Harris T, Wilson PW, Kiel DP (1998) Association between insulin-like growth factor I and bone mineral density in older women and men: the framingham Heart study. J Clin Endocrinol Metab 83 (12): 4257–62PubMedCrossRefGoogle Scholar
  36. Li Voon Chong JS, Benbow S, Foy P, Wallymahmed ME, Wile D, MacFarlane IA (2000) Elderly people with hypothalamic pituitary disease and growth hormone deficiency: lipid profiles, body composition and quality of life compared with control subjects. Clin Endocrinol 53: 551–559CrossRefGoogle Scholar
  37. Li Voon Chong JS, Groves T, Foy P, Wallymahmed ME, MacFarlane IA (2002) Elderly people with hypothalamic pituitary disease and untreated GH deficiency: clinical outcome, body composition, lipid profiles and quality of life after 2 years compared to controls. Clin Endocrinol 56 (2): 175–81.CrossRefGoogle Scholar
  38. Lissett C and Shalet SM Insulin like growth factor-1 generation test: Peripheral responsiveness to growth hormone is not decreased with ageing Clin Endocrinol (in press)Google Scholar
  39. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ (1999) Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 7: 91 (7), 620–5.CrossRefGoogle Scholar
  40. Maheshwari H, Sharma L, and Baumann G (1996) Decline of plasma growth hormone binding protein in old age. J Clin Endocrinol Metab 81: 995–997PubMedCrossRefGoogle Scholar
  41. Monson JP, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Stahl E, Thoren M, Westberg B, Wilton P, Wuster C (2000) Growth hormone deficiency and replacement in elderly hypopituitary adults. Clin Endocrinol 53: 281–289CrossRefGoogle Scholar
  42. Muggeo M, Fedele D, Tiengo A, Molinari M, Crepaldi G (1975) Human growth hormone and cortisol responses to insulin stimulation in aging. J Gerontol 30: 546–551PubMedCrossRefGoogle Scholar
  43. Munzer T, Harman SM, Hees P, Shapiro E, Christmas C, Bellantoni MF, Stevens TE, O’Connor KG, Pabst KM, St Clair C, Sorkin JD, Blackman MR (2001) Effects of GH and/ or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men. J Clin Endocrinol Metab 86: 3604–3610PubMedCrossRefGoogle Scholar
  44. O’Connor KG, Tobin JD, Harman SM, Plato CC, Roy TA, Sherman SS, Blackman MR (1998) Serum levels of insulin-like growth factor-I are related to age and not to body composition in healthy women and men. J Gerontol A Biol Sci Med Sci: 53 (3) M176–82PubMedCrossRefGoogle Scholar
  45. O’Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM (1993) Increased bone density after recombinant growth hormone therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab 76: 1344–1348PubMedCrossRefGoogle Scholar
  46. Papadakis MA, Grady D, Tierney MJ, Black D, Wells L, Grunfeld C (1995) Insulin-like growth factor-1 and functional status in healthy older men. J Am Geriatr Soc 43 (12): 1350–5PubMedGoogle Scholar
  47. Papadakis MA, Grady D, Black D, Tierney MJ, Gooding GA, Schambelan M, Grunfeld C (1996) Growth Hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med 124 (8): 708–16PubMedGoogle Scholar
  48. Pavlov EP, Harman SM, Merriam GR, Gelato MC, Blackman MR (1986) Responses of growth hormone and somatomedin-C to GH releasing hormone in healthy aging men. J Clin Endocrinol Metab 62: 595–600PubMedCrossRefGoogle Scholar
  49. Pfeilschifter J and Ziegler R (1998) Relationship between IGF-I and skeletal ageing Eur J Endocrinol 138: 617–618Google Scholar
  50. Pyka G, Wiswell RA, and Marcus R (1992) Age-dependent effect of resistance exercise on growth hormone secretion in people. J Clin Endocrinol Metab 75: 404–407PubMedCrossRefGoogle Scholar
  51. Rosen T, Wiren L, Wilhelmsen L, et al (1994) Decreased psychological wellbeing in adults with growth hormone deficiency. Clin Endocrinol 40: 111–116CrossRefGoogle Scholar
  52. Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming GA, Bain RP (1981) Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest 67 (5): 1361–9PubMedCrossRefGoogle Scholar
  53. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE (1990) Effects of human growth hormone in men over 60 years old. N Engl J Med 323: 1–6PubMedCrossRefGoogle Scholar
  54. Shibasaki T, Shizume K, Nakahara M, Masuda A, Jibiki K, Demura H, Wakabayashi I, Ling N (1984) Age related changes in growth hormone response to growth hormone releasing factor in man. J Clin Endocrinol Metab 58 (1): 212–4PubMedCrossRefGoogle Scholar
  55. Sugimoto T, Nakaoka D, Nasu M, Kanzawa M, Sugishita T, Chihara K (1999) Effect of recombinant human growth hormone in elderly osteoporotic women. Clin Endocrinol 51: 715–724CrossRefGoogle Scholar
  56. Taaffe DR, Pruitt L, Reim J, Hintz RL, Butterfield G, Hoffman AR, Marcus R (1994) Effect of recombinant human growth hormone on muscle strength response to resistance exercise in elderly men. J Clin Endocrinol Metab 79: 1361–1366PubMedCrossRefGoogle Scholar
  57. Taaffe DR, Thompson JL, Butterfield GE, Hoffman AR, Marcus R (2001) Recombinant human growth hormone, but not insulin like growth factor-1, enhances central fat loss in postmenopausal women undergoing a diet and exercise program. Horm Metab Res 33 (3): 156–62PubMedCrossRefGoogle Scholar
  58. Toogood AA, O’Neill PA, Shalet SM (1996) Beyond the somatopause: growth hormone deficiency in adults over the age of 60 years. J Clin Endocrinol Metab 81: 460–465PubMedCrossRefGoogle Scholar
  59. Toogood AA, Adams JE, O’Neill PA, Shalet SM (1996) Body composition in growth hormone deficient adults over the age of 60 years. Clin Endocrinol 45: 399–405CrossRefGoogle Scholar
  60. Toogood AA, Adams JE, O’Neill PA, Shalet SM (1997) Elderly patients with adult onset growth hormone deficiency are not osteopaenic. J Clin Endocrinol Metab 82: 1462–1466PubMedCrossRefGoogle Scholar
  61. Toogood AA, Jones J, O’Neill PA, Thorner MO, Shalet SM (1998) The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic pituitary disease. Clin Endocrinol 48: 569–576CrossRefGoogle Scholar
  62. Toogood AA and Shalet SM (1999) growth hormone replacement therapy in the elderly with hypothalamic pituitary disease: A dose finding study J Clin Endocrinol Metab 84: 131–136Google Scholar
  63. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, Lamberts SW, Oostra BA, Pols HA, van Duijn CM (2001) A polymorphism in the gene for IGF-1 functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 50 (3): 637–42PubMedCrossRefGoogle Scholar
  64. Van Cauter E, Leproult R, and Plat L (2000) Age related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. DAMA 284 (7); 861–868Google Scholar
  65. Van der Lely AJ, Lamberts SW, Jauch KW, Swierstra BA, Hertlein H, Danielle De Vries D, Birkett MA, Bates PC, Blum WF,Attanasio AF (2000) Use of GH in elderly patients with accidental hip fracture. Eur J Endocrinol 143 (5): 585–592.Google Scholar
  66. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G (1991) Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 72: 51–59PubMedCrossRefGoogle Scholar
  67. Wallymahmed ME, Foy P, Shaw D, Hutcheon R, Edwards RH, MacFarlane IA (1997) Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of GH replacement therapy for up to 3 years. Clin Endocrinol 48: 613–620Google Scholar
  68. Welle S, Thornton C, Statt M, McHenry B (1996) Growth Hormone increases muscle mass and strength but does not rejuvenate myofibrillar protein synthesis in healthy subjects over 60 years old. J Clin Endocrinol Metab 81 (9): 3239–43PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • S. K. Abdul Shakoor
    • 1
  • Andrew A. Toogood
    • 2
  • Stephen M. Shalet
    • 1
  1. 1.Department of EndocrinologyChristie HospitalManchesterUK
  2. 2.Department of Medicine, Division of Medical SciencesQueen Elizabeth HospitalEdgbaston, BirminghamUK

Personalised recommendations